Mizolastine
From Self-sufficiency
| File:Mizolastine.png | |
| Systematic (IUPAC) name | |
|---|---|
|
2-[{1-[1-(4-fluorobenzyl)-1H-benzimidazol-2-yl]piperidin-4-yl}(methyl)amino]pyrimidin-4(1H)-one | |
| Clinical data | |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | 108612-45-9 |
| ATC code | R06AX25 (WHO) |
| PubChem | CID 65906 |
| Chemical data | |
| Formula | C24H25FN6O |
| Molar mass | 432.493 g/mol[[Script error: No such module "String".]] |
Mizolastine (Mizollen) is a once daily, non-sedating antihistamine. It blocks H1 receptors and is commonly fast-acting. It does not prevent the actual release of histamine from mast cells, just prevents it binding to receptors. Side effects can include dry mouth and throat.[1]
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
 |
This pharmacology-related article is a stub. You can help ssf by expanding it. |
- ↑ "MIZOLASTINE: British National Formulary". Retrieved 2010-02-01.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Pharmacology stubs
- Benzimidazoles
- Piperidines
- H1 receptor antagonists
- Organofluorides
- Pyrimidones
- 2Fix
